Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro dynamic method for evaluating the hemolytic potential of intravenous solutions.

E K Obeng, D E Cadwallader

    Journal of Parenteral Science and Technology : a Publication of the Parenteral Drug Association
    |July 1, 1989
    PubMed
    Summary

    A new in vitro method simulates blood flow to assess intravenous solution safety. Flow rate significantly impacts red blood cell (RBC) damage, with higher flow reducing hemolysis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of solute structure on deviations from the log-linear solubility equation in propylene glycol:water mixtures.

    Journal of pharmaceutical sciences·1991
    Same author

    Stability of pibenzimol hydrochloride in commonly used infusion solutions and after filtration.

    American journal of hospital pharmacy·1989
    Same author

    Stability of terbutaline sulfate repackaged in disposable plastic syringes.

    American journal of hospital pharmacy·1987
    Same author

    Pharmacokinetics of tiazofurin in dogs.

    Biopharmaceutics & drug disposition·1987
    Same author

    Blood level studies of all-trans- and 13-cis-retinoic acids in rats using different formulations.

    Journal of pharmaceutical sciences·1982
    Same author

    Improved and rapid high-performance liquid chromatographic assay for 13-cis-retinoic acid or all-trans-retinoic acid.

    Journal of pharmaceutical sciences·1982

    Area of Science:

    • Biomedical Engineering
    • Pharmacology
    • Hematology

    Background:

    • Intravenous (IV) solutions require rigorous safety evaluation.
    • Assessing the hemolytic potential of IV formulations is crucial for patient safety.
    • Existing methods may not fully replicate physiological conditions.

    Purpose of the Study:

    • To develop and validate a dynamic in vitro method for evaluating the hemolytic potential of IV solutions.
    • To simulate blood circulation dynamics at IV injection sites.
    • To identify key physical variables influencing hemolysis during IV administration.

    Main Methods:

    • Development of an in vitro flow system mimicking blood circulation.
    • Systematic variation of physical parameters: tubing diameter, red blood cell (RBC) suspension flow rate, and injection rate.

    Related Experiment Videos

  • Quantification of hemolysis using a 50% propylene glycol (PG) in 0.9% NaCl solution as a test case.

    • Main Results:

    • Physical variables significantly influence the degree of hemolysis.
    • Higher RBC suspension flow rates at the injection site demonstrably reduce hemolysis.
    • Example: 50% PG in 0.9% NaCl caused 78.4% hemolysis at 12 mL/min RBC flow, decreasing to 33.5% at 48 mL/min RBC flow.

    Conclusions:

    • The developed dynamic in vitro method effectively simulates IV injection conditions.
    • Flow rate is a critical factor in mitigating hemolysis caused by IV solutions.
    • This method provides a valuable tool for predicting the in vivo hemolytic potential of pharmaceutical formulations.